- Home
- NQP vs VSTM Comparison
NQP vs VSTM Comparison
Compare NQP & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NQP
- VSTM
- Stock Information
- Founded
- NQP 1990
- VSTM 2010
- Country
- NQP United States
- VSTM United States
- Employees
- NQP N/A
- VSTM N/A
- Industry
- NQP Trusts Except Educational Religious and Charitable
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- NQP Finance
- VSTM Health Care
- Exchange
- NQP Nasdaq
- VSTM Nasdaq
- Market Cap
- NQP 412.0M
- VSTM 425.9M
- IPO Year
- NQP N/A
- VSTM 2012
- Fundamental
- Price
- NQP $11.03
- VSTM $4.93
- Analyst Decision
- NQP
- VSTM Strong Buy
- Analyst Count
- NQP 0
- VSTM 8
- Target Price
- NQP N/A
- VSTM $12.71
- AVG Volume (30 Days)
- NQP 58.4K
- VSTM 2.6M
- Earning Date
- NQP 01-01-0001
- VSTM 08-07-2025
- Dividend Yield
- NQP 3.21%
- VSTM N/A
- EPS Growth
- NQP N/A
- VSTM N/A
- EPS
- NQP N/A
- VSTM N/A
- Revenue
- NQP N/A
- VSTM $10,000,000.00
- Revenue This Year
- NQP N/A
- VSTM $129.06
- Revenue Next Year
- NQP N/A
- VSTM $306.32
- P/E Ratio
- NQP N/A
- VSTM N/A
- Revenue Growth
- NQP N/A
- VSTM N/A
- 52 Week Low
- NQP $9.65
- VSTM $2.10
- 52 Week High
- NQP $11.89
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- NQP 45.09
- VSTM 30.80
- Support Level
- NQP $11.02
- VSTM $5.73
- Resistance Level
- NQP $11.20
- VSTM $6.62
- Average True Range (ATR)
- NQP 0.06
- VSTM 0.46
- MACD
- NQP -0.00
- VSTM -0.17
- Stochastic Oscillator
- NQP 23.91
- VSTM 0.84
About NQP Nuveen Pennsylvania Quality Municipal Income Fund
Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.